HBM Partners

HBM Partners is a Swiss private equity firm specializing in healthcare investments, managing assets totaling USD 2.1 billion. Founded in 2001, the firm focuses on venture, growth, and buy-out financings of private companies, as well as investments in public companies within the biopharmaceuticals, medical technology, diagnostics, and healthcare sectors. Their geographical focus spans Europe, North America, India, China, and other emerging markets. HBM Partners is regulated by the Swiss Financial Market Supervisory Authority (FINMA) and advises the SIX Swiss Exchange-listed HBM Healthcare Investments Ltd, along with several specialized public and private equity investment funds. The firm has a track record of over 100 investments, resulting in more than 60 trade sales and IPOs, with investments typically ranging between USD 5 million and 50 million. HBM Partners' team of experienced professionals sources, analyzes, and engages in private and public healthcare investments, supporting the growth of portfolio companies through all stages of development by leveraging its experience and worldwide industry network.

The firm's investment strategy encompasses various stages, including early-stage, growth, and buyout investments, targeting companies in the biopharmaceuticals, medical technology, diagnostics, and healthcare sectors. HBM Partners has a diverse geographical focus, investing in companies across Europe, North America, India, China, and other emerging markets. The firm's portfolio includes a range of companies in the healthcare sector, with investments typically ranging between USD 5 million and 50 million. HBM Partners' team of experienced professionals sources, analyzes, and engages in private and public healthcare investments, supporting the growth of portfolio companies through all stages of development by leveraging its experience and worldwide industry network.

HBM Partners' track record includes over 100 investments, resulting in more than 60 trade sales and IPOs, with significant value creation. The firm's investment philosophy emphasizes adding value by leveraging its experience and worldwide industry network to support the growth of portfolio companies through all stages of development. HBM Partners is a trusted source of capital for entrepreneurial biopharmaceutical and healthcare companies, focusing on adding value by leveraging its experience and worldwide industry network. The firm's team of experienced professionals sources, analyzes, and engages in private and public healthcare investments, supporting the growth of portfolio companies through all stages of development by leveraging its experience and worldwide industry network.